| Artulde Point-du-jour, | |
|
927 Lafayette Ave, Union, NJ 07083-6720 | |
| (908) 764-6722 | |
| Not Available |
| Full Name | Artulde Point-du-jour |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse |
| Location | 927 Lafayette Ave, Union, New Jersey |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1457891319 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163W00000X | Registered Nurse | 504961 (New York) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Artulde Point-du-jour, 927 Lafayette Ave, Union, NJ 07083-6720 Ph: (908) 764-6722 | Artulde Point-du-jour, 927 Lafayette Ave, Union, NJ 07083-6720 Ph: (908) 764-6722 |
News Archive
The budget plan, developed by House Budget Committee Chairman Paul Ryan, R- Wis., targets a number of Obama administration domestic initiatives. It trims an estimated $261 billion in domestic spending over the next decade and undoes elements of the health law.
Health managers in the UK have virtually been ordered to pay for the drug Herceptin for women with an aggressive form of breast cancer in its early stages.
A new technique to catch cancer early has taken an important step forward thanks to the National Physical Laboratory (NPL). NPL's 'phantoms' will ensure an exciting new screening technique can be relied upon by hospitals to identify early signs of cancer.
Before taking a sip of alcohol at nearly a dozen local bars and restaurants, San Diegans will be reminded of the dangers of mixing alcohol and pregnancy thanks to a beverage coaster campaign led by the new Southern California chapter of the National Organization on Fetal Alcohol Syndrome (SoCal NOFAS), in partnership with University of California, San Diego School of Medicine.
pSivida Corp., a leader in developing sustained release, drug delivery products for treatment of back-of-the-eye diseases, including the investigational drug ILUVIEN® for the treatment of Diabetic Macular Edema (DME), today announced that Alimera Sciences, Inc, pSivida's collaborative partner, received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) regarding its New Drug Application (NDA) for ILUVIEN. The FDA issued the CRL to communicate its decision that the NDA cannot be approved in its present form.
› Verified 7 days ago
Sabine Prince-bataille, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 2165 Morris Ave Ste 3, Union, NJ 07083 Phone: 862-755-7683 | |
Ebiaredo Alofe, NP Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 704 Garden St, Union, NJ 07083 Phone: 908-472-8042 | |
Mariel Anne Mendoza, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 2350 Wickford Rd, Union, NJ 07083 Phone: 347-605-0590 | |
Jennifer Bryans, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 43 Progress St, Union, NJ 07083 Phone: 908-258-8765 | |
Yvrose Thermitus, REGISTERED NURSE Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 642 Carlyle Pl, Union, NJ 07083 Phone: 201-618-3706 | |
Preethi Idiculla, RNFA Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 968 Wendy Ct, Union, NJ 07083 Phone: 917-858-0953 | |
Esther A Eweh, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1514 Rose Ter, Union, NJ 07083 Phone: 973-493-3615 |